Pharmaceuticals, Biotechnology and Life Sciences
TxCell SA has signed a 5-year agreement with MaSTherCell, a Contract Manufacturing Organization (CMO), based in Belgium.
According to this agreement, MaSTherCell will be the exclusive manufacturer in Europe of all products from TxCell’s ASTrIA platform.
Sun Pharmaceutical Industries, largest India-based generic pharmaceutical companies, has received approval from the US FDA for its Abbreviated New Drug Application (ANDA) for generic version of Novartis’ Gleevec.
Anavex has appointed Ulrich Elben, PhD as Vice President of Preclinical Operations, who will be responsible for the pipeline development and optimization.
Premaitha Health said Wednesday that Adgenix has already signed up its first laboratory customer for Premaitha in France, with a signed contract for a minimum of three years to supply LaboSud with the Iona test.
Flood in India’s Chennai suspends operations at Natco Pharma API plant
Savy Akers’ 10,000 square foot production facility in Haikou National Hi-Tech Industrial Zone, Hainan province, is now fully operational.
Horizon Pharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. patent application number entitled “Treatment of Pain with Topical Diclofenac” for a drug Pennsaid 2% w/w.
The estimated number of adolescents dying of AIDS in the Asia Pacific region has more than doubled since 2005, experts said on Monday, warning of a “hidden epidemic”.
UNICEF urged Asian countries to improve teenagers’ access to testing, saying many young people do not know their HIV status because of parental consent requirements for tests.
AHF Marks World AIDS Day with HIV Testing & Awareness Events in 32 Countries; Celebrates Milestone: 500,000 Lives in Care
Celyad advances first NKG2D CAR T-Cell Phase I study